Modulation of seizure activity by a CaV2.3 inhibitor in a rat model of CDKL5 deficiency disorder

Project Details

StatusFinished
Effective start/end date4/03/24 → 30/09/24

Funding

  • Lario Therapeutics Ltd: £38,244.41